NCT05901766

Brief Summary

The goal of this clinical trial is to learn about the effects of iodine-containing multiple micronutrient supplements provided to breastfeeding mothers who live in settings with mild iodine deficiency. The main questions it aims to answer are:

  1. 1.What are the effects of iodine-containing multiple micronutrient supplements provided to breastfeeding mothers on infant development, as measured by electroencephalography/visual evoked potentials?
  2. 2.What are the effects of iodine-containing multiple micronutrient supplements on breast milk concentrations of iodine, and infant iodine and thyroid status?
  3. 3.How do iodine and iron interact with each other to affect thyroid function in the mother during lactation?

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for phase_4

Timeline
11mo left

Started Jan 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress28%
Jan 2026Apr 2027

First Submitted

Initial submission to the registry

June 5, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 13, 2023

Completed
2.6 years until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2027

Last Updated

September 29, 2025

Status Verified

August 1, 2025

Enrollment Period

12 months

First QC Date

June 5, 2023

Last Update Submit

September 24, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Visual Evoked Potentials

    P1 Latency

    6 months post partum

  • BMIC

    Breast Milk Iodine Concentration at 1 month

    1 month post partum

Secondary Outcomes (5)

  • EEG Fc

    6 months

  • Infant HCAZ at 6 months

    6 months

  • Infant UIC

    6 months

  • Infant Tg

    6 months

  • Infant TSH

    6 months

Study Arms (2)

Iodine Containing Multiple Micronutrient (UNIMAP)

EXPERIMENTAL

UNIMAP 1 tablet po once daily from birth to 6 months postpartum

Dietary Supplement: UNIMAP Multiple Micronutrient Supplement

Routine postnatal care

NO INTERVENTION

Routine postnatal care per Ethiopian Ministry of Health guidelines

Interventions

Iodine Containing Multiple Micronutrient Supplement once daily

Iodine Containing Multiple Micronutrient (UNIMAP)

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Intention to breast feed at least 3 months
  • Birth weight \>2000g

You may not qualify if:

  • Intention to primarily feed by alternative sources (formula, animal milk)
  • Multiple pregnancy
  • Infant with major congenital anomalies
  • Infants with severe morbidity or developmental disorder
  • Mother with HIV or chronic renal disease
  • Plan to move out of study catchment area
  • Does not agree to follow up or EEG/VEP

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

MalnutritionBreast Feeding

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic DiseasesFeeding BehaviorBehavior

Central Study Contacts

Anne Lee, MD, MPH

CONTACT

Kaitlin Mason, MPH, BSN

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Individually randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Levinger Family Professor of Pediatrics

Study Record Dates

First Submitted

June 5, 2023

First Posted

June 13, 2023

Study Start

January 1, 2026

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

April 1, 2027

Last Updated

September 29, 2025

Record last verified: 2025-08